IRCCS San Raffaele
Quick facts
Marketed products
- Antiarrhythmic Drug Therapy
- "Drug:Carvedilol" and "Drug:Ivabradine"
- Insulin glargine plus insulin analogues
Phase 3 pipeline
- Atazanavir/ritonavir monotherapy · Infectious Disease
Atazanavir/ritonavir inhibits HIV protease to prevent viral replication, with ritonavir boosting atazanavir levels through CYP3A4 inhibition. - NUCS · Infectious Diseases
NUCS is a small molecule that targets the SARS-CoV-2 main protease. - PEG-IFNa 2a · Oncology
PEG-IFNa 2a is a pegylated form of interferon alpha-2a, which works by stimulating the body's immune system to fight viral infections and cancer cells.
Phase 2 pipeline
- 99m-TC-PSMA-I&S · Oncology
99m-TC-PSMA-I&S is a radiopharmaceutical that targets prostate-specific membrane antigen (PSMA) for diagnostic imaging of prostate cancer. - capecitabine and mitomycin
- Defibrotide Injection · Oncology
Phosphodiesterase inhibitor - Myelostim · Other
- supplementary treatment with vitamin D
- Treosulfan IV
Phase 1 pipeline
- L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract
- PCA Morphine
- various neoadjuvant therapies
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: